An update on the therapy of canine demodicosis
- PMID: 22488596
An update on the therapy of canine demodicosis
Abstract
Canine demodicosis, a disease caused by a proliferation of Demodex mites, typically leads to alopecia, comedones, follicular papules and pustules, scaling, and crusting. It may be treated with either amitraz rinses or macrocyclic lactones. Amitraz rinse is approved for application every 2 weeks at a concentration of 0.025%. Higher concentrations and more frequent applications increase the success rate but also increase the risk for adverse effects. Ivermectin is used at 0.3 to 0.6 mg/kg/d PO and moxidectin at 0.2 to 0.5 mg/kg/d PO. Both drugs may cause adverse neurologic effects in sensitive dogs. Milbemycin oxime at 1 to 2 mg/kg/d PO is a safer treatment option. A weekly spot-on combination of 2.5% moxidectin and 10% imidacloprid is recommended for milder forms of the disease.
Similar articles
-
Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.Vet Parasitol. 2014 Oct 15;205(3-4):687-96. doi: 10.1016/j.vetpar.2014.08.021. Epub 2014 Sep 4. Vet Parasitol. 2014. PMID: 25262617 Clinical Trial.
-
Treatment protocols for demodicosis: an evidence-based review.Vet Dermatol. 2004 Apr;15(2):75-89. doi: 10.1111/j.1365-3164.2004.00344.x. Vet Dermatol. 2004. PMID: 15030556 Review.
-
Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.Vet Rec. 2012 Sep 15;171(11):272. doi: 10.1136/vr.100843. Epub 2012 Jul 11. Vet Rec. 2012. PMID: 22791522
-
Treatment of demodicosis in dogs: 2011 clinical practice guidelines.Vet Dermatol. 2012 Apr;23(2):86-96, e20-1. doi: 10.1111/j.1365-3164.2011.01026.x. Epub 2012 Feb 13. Vet Dermatol. 2012. PMID: 22329600 Review.
-
Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.Parasitol Res. 2005 Oct;97 Suppl 1:S89-S96. doi: 10.1007/s00436-005-1450-3. Parasitol Res. 2005. PMID: 16228281 Clinical Trial.
Cited by
-
Efficacy of a topical application of Certifect® (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis.Parasite. 2013;20:46. doi: 10.1051/parasite/2013046. Epub 2013 Nov 21. Parasite. 2013. PMID: 24256940 Free PMC article. Clinical Trial.
-
Juvenile-onset and adult-onset demodicosis in dogs in the UK: prevalence and breed associations.J Small Anim Pract. 2020 Jan;61(1):32-41. doi: 10.1111/jsap.13067. Epub 2019 Oct 4. J Small Anim Pract. 2020. PMID: 31584708 Free PMC article.
-
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.Parasit Vectors. 2018 Sep 10;11(1):506. doi: 10.1186/s13071-018-3083-2. Parasit Vectors. 2018. PMID: 30201031 Free PMC article.
-
Digit loss due to Demodex spp. infestation in a dog: clinical and pathological features.Open Vet J. 2013;3(1):53-5. Epub 2013 May 20. Open Vet J. 2013. PMID: 26623312 Free PMC article.
-
Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.Parasite. 2016;23:14. doi: 10.1051/parasite/2016014. Epub 2016 Mar 24. Parasite. 2016. PMID: 27012161 Free PMC article. Clinical Trial.